SYNGENESyngene International Ltd
Syngene slips to a Q1 net loss as revenue falls 16% YoY; transition year begins weak
cro cdmo · contract research · librela destocking
Research Reports
29 Jul 2026
28 Jul 2026
ZENOTECHZENOTECH LABORATORIES LTD.
Zenotech posts ₹0.46 Cr Q1 FY27 loss, reversing YoY profit; loss narrows 86% QoQ
pharmaceuticals · swing to loss · margin compression
SYNGENESyngene International Ltd
Leadership Transition & Continuity: What Q1 Revenue Can Tell Us
CRO · contract-research · pharma-services
27 Jul 2026
SENORESSenores Pharmaceuticals Ltd
Senores Q1: consolidated PAT ₹30.5 Cr, EBITDA +87% YoY as margins expand ~800bps
pharmaceuticals · andas · regulated markets
TORNTPHARMTORRENT PHARMACEUTICALS LTD.
Integration milestone and margin momentum on tap as Torrent reports Q1
merger integration · organic growth · EBITDA margins
MANKINDMankind Pharma Ltd
Expect momentum on scale; watch how divestment reshapes the play
Q1FY27 · revenue-growth · margin-track
26 Jul 2026
25 Jul 2026
DRREDDYDR.REDDY'S LABORATORIES LTD.
Dr Reddy's Q1 PAT sinks 69% YoY to ₹436 Cr as lenalidomide fades, semaglutide hit
pharma · us generics slowdown · lenalidomide roll-off
SUNPHARMASUN PHARMACEUTICAL INDUSTRIES LTD.
Specialty Traction and Organon Integration Timing Set Q1 Tone
specialty drugs · Organon acquisition · margin expansion
24 Jul 2026
23 Jul 2026
20 Jul 2026
BAJAJHCAREBajaj Healthcare Ltd
Bajaj Healthcare Q1 PAT +16% YoY to ₹13.7 Cr; margins expand after one-off Q4 loss
Pharma & Biotech · earnings · quarterly results
VENUSREMVENUS REMEDIES LTD.
Venus Remedies Q1 FY27: consolidated PAT jumps ~139% YoY to ₹22.97 Cr, margins expand
Pharma & Biotech · earnings · quarterly results
16 Jul 2026
15 Jul 2026
14 Jul 2026
